GSK, Teva Face Antitrust Class Action Over Lamictal Deal
A drug distributor lodged a putative antitrust class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. in New Jersey federal court Wednesday, accusing the companies of conspiring to keep a...To view the full article, register now.
Already a subscriber? Click here to view full article